Cargando…

COVID-19 vaccine acceptability, and uptake among people living with HIV in Uganda

BACKGROUND: Despite being a priority population for COVID-19 vaccination, limited data are available regarding acceptability of COVID-19 vaccines among people living with HIV (PLWH) in Sub-Saharan Africa. We described COVID-19 vaccine acceptability and factors associated with vaccine acceptability a...

Descripción completa

Detalles Bibliográficos
Autores principales: Muhindo, Richard, Okoboi, Stephen, Kiragga, Agnes, King, Rachel, Arinaitwe, Walter Joseph, Castelnuovo, Barbara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9718389/
https://www.ncbi.nlm.nih.gov/pubmed/36459514
http://dx.doi.org/10.1371/journal.pone.0278692
_version_ 1784843081376333824
author Muhindo, Richard
Okoboi, Stephen
Kiragga, Agnes
King, Rachel
Arinaitwe, Walter Joseph
Castelnuovo, Barbara
author_facet Muhindo, Richard
Okoboi, Stephen
Kiragga, Agnes
King, Rachel
Arinaitwe, Walter Joseph
Castelnuovo, Barbara
author_sort Muhindo, Richard
collection PubMed
description BACKGROUND: Despite being a priority population for COVID-19 vaccination, limited data are available regarding acceptability of COVID-19 vaccines among people living with HIV (PLWH) in Sub-Saharan Africa. We described COVID-19 vaccine acceptability and factors associated with vaccine acceptability among PLWH in Uganda. METHODS: This was a cross-sectional study conducted among PLWH, aged ≥18 years, enrolled participants who were seeking HIV care from six purposely selected accredited ART clinics in Kampala. We obtained data on vaccine acceptability defined as willingness to accept any of the available COVID-19 vaccines using interviewer-administered questionnaires. In addition, we assessed vaccination status, complacency regarding COVID-19 disease, vaccine confidence, and vaccine convenience. Factors associated with COVID-19 vaccine acceptability were evaluated using modified Poisson regression with robust standard errors. RESULTS: We enrolled 767 participants of whom 485 (63%) were women. The median age was 33 years [interquartile range (IQR) 28–40] for women and 40 years [IQR], (34–47) for men. Of the respondents 534 (69.6%,95% confidence interval [CI]: 66.3%-72.8%) reported receiving at least one vaccine dose, with women significantly more likely than men to have been vaccinated (73% vs. 63%; p = 0.003). Among the unvaccinated 169 (72.7%, 95% CI: 66.6%-78.0%) were willing to accept vaccination, had greater vaccine confidence (85.9% had strong belief that the vaccines were effective; 81.9% that they were beneficial and 71% safe for PLWH; 90.5% had trust in health care professionals or 77.4% top government officials), and believed that it would be easy to obtain a vaccine if one decided to be vaccinated (83.6%). Vaccine acceptability was positively associated with greater vaccine confidence (adjusted prevalence ratio [aPR] 1.44; 95% CI: 1.08–1.90), and positive perception that it would be easy to obtain a vaccine (aPR 1.57; 95% CI: 1.26–1.96). CONCLUSION: vaccine acceptance was high among this cohort of PLWH, and was positively associated with greater vaccine confidence, and perceived easiness (convince) to obtained the vaccine. Building vaccine confidence and making vaccines easily accessible should be a priority for vaccination programs targeting PLWH.
format Online
Article
Text
id pubmed-9718389
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-97183892022-12-03 COVID-19 vaccine acceptability, and uptake among people living with HIV in Uganda Muhindo, Richard Okoboi, Stephen Kiragga, Agnes King, Rachel Arinaitwe, Walter Joseph Castelnuovo, Barbara PLoS One Research Article BACKGROUND: Despite being a priority population for COVID-19 vaccination, limited data are available regarding acceptability of COVID-19 vaccines among people living with HIV (PLWH) in Sub-Saharan Africa. We described COVID-19 vaccine acceptability and factors associated with vaccine acceptability among PLWH in Uganda. METHODS: This was a cross-sectional study conducted among PLWH, aged ≥18 years, enrolled participants who were seeking HIV care from six purposely selected accredited ART clinics in Kampala. We obtained data on vaccine acceptability defined as willingness to accept any of the available COVID-19 vaccines using interviewer-administered questionnaires. In addition, we assessed vaccination status, complacency regarding COVID-19 disease, vaccine confidence, and vaccine convenience. Factors associated with COVID-19 vaccine acceptability were evaluated using modified Poisson regression with robust standard errors. RESULTS: We enrolled 767 participants of whom 485 (63%) were women. The median age was 33 years [interquartile range (IQR) 28–40] for women and 40 years [IQR], (34–47) for men. Of the respondents 534 (69.6%,95% confidence interval [CI]: 66.3%-72.8%) reported receiving at least one vaccine dose, with women significantly more likely than men to have been vaccinated (73% vs. 63%; p = 0.003). Among the unvaccinated 169 (72.7%, 95% CI: 66.6%-78.0%) were willing to accept vaccination, had greater vaccine confidence (85.9% had strong belief that the vaccines were effective; 81.9% that they were beneficial and 71% safe for PLWH; 90.5% had trust in health care professionals or 77.4% top government officials), and believed that it would be easy to obtain a vaccine if one decided to be vaccinated (83.6%). Vaccine acceptability was positively associated with greater vaccine confidence (adjusted prevalence ratio [aPR] 1.44; 95% CI: 1.08–1.90), and positive perception that it would be easy to obtain a vaccine (aPR 1.57; 95% CI: 1.26–1.96). CONCLUSION: vaccine acceptance was high among this cohort of PLWH, and was positively associated with greater vaccine confidence, and perceived easiness (convince) to obtained the vaccine. Building vaccine confidence and making vaccines easily accessible should be a priority for vaccination programs targeting PLWH. Public Library of Science 2022-12-02 /pmc/articles/PMC9718389/ /pubmed/36459514 http://dx.doi.org/10.1371/journal.pone.0278692 Text en © 2022 Muhindo et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Muhindo, Richard
Okoboi, Stephen
Kiragga, Agnes
King, Rachel
Arinaitwe, Walter Joseph
Castelnuovo, Barbara
COVID-19 vaccine acceptability, and uptake among people living with HIV in Uganda
title COVID-19 vaccine acceptability, and uptake among people living with HIV in Uganda
title_full COVID-19 vaccine acceptability, and uptake among people living with HIV in Uganda
title_fullStr COVID-19 vaccine acceptability, and uptake among people living with HIV in Uganda
title_full_unstemmed COVID-19 vaccine acceptability, and uptake among people living with HIV in Uganda
title_short COVID-19 vaccine acceptability, and uptake among people living with HIV in Uganda
title_sort covid-19 vaccine acceptability, and uptake among people living with hiv in uganda
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9718389/
https://www.ncbi.nlm.nih.gov/pubmed/36459514
http://dx.doi.org/10.1371/journal.pone.0278692
work_keys_str_mv AT muhindorichard covid19vaccineacceptabilityanduptakeamongpeoplelivingwithhivinuganda
AT okoboistephen covid19vaccineacceptabilityanduptakeamongpeoplelivingwithhivinuganda
AT kiraggaagnes covid19vaccineacceptabilityanduptakeamongpeoplelivingwithhivinuganda
AT kingrachel covid19vaccineacceptabilityanduptakeamongpeoplelivingwithhivinuganda
AT arinaitwewalterjoseph covid19vaccineacceptabilityanduptakeamongpeoplelivingwithhivinuganda
AT castelnuovobarbara covid19vaccineacceptabilityanduptakeamongpeoplelivingwithhivinuganda